Guaifenesin
Product Images NDC 51316-070

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Guaifenesin (NDC 51316-070). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cvs Pharmacy, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (600 mg Tablet Blister Pack Carton)

Principal Display Panel (600 mg Tablet Blister Pack Carton)
This is a drug information sheet for Guaifenesin extended-release tablets. This medicine is an expectorant that helps relieve chest congestion by thinning and loosening mucus from the respiratory tract. It is available in a 600 mg tablet form that provides immediate and extended release of the active ingredient. This drug is not recommended for children under 12, and those who are pregnant or breastfeeding should consult a doctor before use. The recommended dosage is one to two tablets every 12 hours, not exceeding four tablets in 24 hours. The medicine should be taken with a full glass of water and not crushed, chewed, or broken. If symptoms persist or worsen, a doctor should be consulted. The carton contains important information and the end panel shows the expiration date.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.